Single Rituximab Infusion Safe and Shown to Deplete B Cells After STEMI
The investigators assessed the safety, feasibility, and pharmacodynamic effect of rituximab administered to patients with acute ST elevation MI.
Myocardial Infarction
More Bleeding Events After PCI in Women With Baseline Risk Factors
The researchers explored the association of sex with outcomes among patients treated with ticagrelor monotherapy vs ticagrelor plus aspirin.
Atypical MI Symptom Presentation Linked to Worse Outcomes
Patients presenting with atypical symptoms of myocardial infarction (MI) when calling for help are less likely to receive an emergency dispatch and have increased mortality.
Neighborhood, Socioeconomic Factors Affect Survival After Myocardial Infarction
Neighborhood and socioeconomic factors play an important role in long-term survival in younger patients after a myocardial infarction (MI).
COVID-19 Increases Mortality Risk in Patients With Acute Coronary Syndrome
The researchers’ aim was to determine the demographics, angiographic findings, and in-hospital outcomes of COVID-19 ACS patients and compare these with pre-COVID-19 cohorts.
Major In-Hospital Bleeding Increases Mortality Risk in AMI Complicated by Cardiogenic Shock
The researchers’ goal was to study the incidence and impact of major in-hospital bleeding on all-cause mortality in patients with acute myocardial infarction complicated by cardiogenic shock who undergo PCI.
Better Coronary Microvascular Function With Ticagrelor vs Clopidogrel in Non-ST Elevation ACS
Researchers wanted to compare ticagrelor with clopidogrel in patients with non-ST elevation acute coronary syndrome to fill a gap in the data about the performance of these drugs.
Preventive Statin Initiation Reduces STEMI Risk as Initial Manifestation of CVD
This study sought to determine whether statin initiation for the primary prevention of CVD would improve outcomes.
Effects of Aspirin Therapy on Thrombotic Complications in COVID-19
Researchers conducted a review of patients who were tested for COVID-19 and received aspirin or NSAIDS to assess whether aspirin was protective from death, myocardial infarction, or VTE.
Does CYP2C19*17 Status in Those Taking Clopidogrel Modify Post-PCI MACE Risk?
The researchers sought to identify major interaction effects between clopidogrel and CYP2C19*17 status, in terms of risk for MACE and bleeding events after PCI.
- Loading...
Loading...
Next post in ACC 2021 Meeting Highlights
Loading... 
Loading...